Published on in Vol 23, No 10 (2021): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/26890, first published
.
Journals
- Maeda H, Uchida M, Kusano M, Tsukamoto K, Yamanoi M. Characteristics of the Compassionate Use Program in Japan: An Analysis of Expanded Access Clinical Trials from 2016 to 2021. Clinical Pharmacology & Therapeutics 2022;112(4):817 View
- Vermeulen S, Polak T, Bunnik E. Expanded access to investigational drugs in psychiatry: A systematic review. Psychiatry Research 2023;329:115554 View
- Miranda A, Rubovits E, Mudar R, Leung V, Raj M. Where are caregivers in the clinical trial? Evaluation of caregiver responsibilities in Alzheimer's disease and related dementias clinical trials. Alzheimer's & Dementia 2023;19(11):5316 View
- Bloom T, Bonini K, Gutierrez‐Kapheim M, Kinsley L, Smith M, Duquette D. Exploring genetic counselors' practice of discussing clinical trials with patients. Journal of Genetic Counseling 2024 View
- Rubovits E, Yedavalli A, Sadruddin S, Lavari K, Mudar R, Leung V, Cothran F, Raj M. Engaging Asian American Family Caregivers in Clinical Trials: Awareness, Preferences, and Concerns. Journal of Applied Gerontology 2024 View